NEW YORK (TheStreet) -- RATINGS CHANGES

Alibaba (BABA - Get Report) was initiated with a buy rating at Cantor Fitzgerald. Twelve-month price target is $90. Company has an unfair competitive advantage with outsized growth and margin profiles, Cantor said.

Bio-Rad Laboratories (BIO) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: BIO Ratings Report.

Oracle (ORCL - Get Report) was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $42. Database license sales are slowing down, Deutsche Bank said.

Koss (KOSS - Get Report) was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: KOSS Ratings Report.

Sprouts (SFM - Get Report) was initiated with an overweight rating at Barclays. Twelve-month price target is $37. Company can average 33% earnings growth over the next five years, Barclays said.

Texas Capital (TCBI - Get Report) was upgraded at Wunderlich to buy from hold. Twelve-month price target is $75. Company is the most sensitive to higher interest rates, Wunderlich said.

VF (VFC) was upgraded at Keybanc to buy. Twelve-month price target is $80. Estimates were also increased, as the company will likely improve brands and could make acquisitions, Keybanc said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.